Identification of novel human immunodeficiency virus type 1-inhibitory peptides based on the antimicrobial peptide database

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 3, 2010, Pages 1343-1346

  Wang, Guangshun ^a   Watson, Karen M ^b   Peterkofsky, Alan ^c   Buckheit Jr , Robert W ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b ImQuest Biosciences   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APIDAECIN IA; BREVININ 2; BUFORIN II; CLAVANIN B; D70 PROTEIN; D74 PROTEIN; D76 PROTEIN; D88 PROTEIN; DERMASEPTIN S9; DROSOCIN; GLK 19 PEPTIDE; HYPOSIN 5; LYCOTOXIN I; MASTOPARAN M; MAXIMIN H5; METALNIKOWIN I; MISGURIN; PARASIN I; PGLA PROTEIN; PISCIDIN 3; POLYPEPTIDE ANTIBIOTIC AGENT; PONERICIN L2; PSEUDIN 1; RANATUERIN 9; SPINIGERIN; STYELIN A; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE;

AMINO ACID COMPOSITION; AMINO ACID SEQUENCE; AMPHIBIA; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DATA BASE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SCREENING;

AMINO ACID SEQUENCE; AMPHIBIAN PROTEINS; ANIMALS; ANTI-HIV AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; DATABASES, PROTEIN; DRUG DESIGN; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77149155289     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01448-09     Document Type: Article

References (23)

1. Bergman, P., L. Walter-Jallow, K. Broliden, B. Agerberth, and J. Soderlund. 2007. The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr. HIV Res. 5:410-415.
2. Buckheit, R. W., Jr. 2001. Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection. Expert Opin. Investig. Drugs 10:1423-1442.
3. Buckheit, R. W., Jr., T. L. Kinjerski, V. Fliakas-Boltz, J. D. Russell, T. L. Stup, L. A. Pallansch, W. G. Brouwer, D. C. Dao, W. A. Harrison, and R. J. Schultz. 1995. Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide. Antimicrob. Agents Chemother. 39:2718-2727.
4. Cho, J. H., B. H. Sung, and S. C. Kim. 2009. Buforins: histone-H2A-derived antimicrobial peptides from toad stomach. Biochim. Biophys. Acta 1788: 1564-1569.
5. Cole, A. M. 2005. Antimicrobial peptide microbicides targeting HIV. Protein Pept. Lett. 12:41-47.
6. Foley, G. E., H. Lazarus, S. Farber, B. G. Uzman, B. A. Boone, and R. E. Mccarthy. 1965. Continuous culture of human lymphoblasts from peripheral blood of a child with acute leukemia. Cancer 18:522-529.
7. Ireland, D. C., C. K. Wang, J. A. Wilson, K. R. Gustafson, and D. J. Craik. 2008. Cyclotides as natural anti-HIV agents. Biopolymers 90:51-60.
8. Jenssen, H., P. Hamill, and R. E. Hancock. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511.
9. Lehrer, R. I. 2007. Multispecific myeloid defensins. Curr. Opin. Hematol. 14:16-21.
10. Li, X., Y. Li, A. Peterkofsky, and G. Wang. 2006. NMR studies of aurein 1.2 analogs. Biochim. Biophys. Acta 1758:1203-1214.
11. Nara, P. L., W. C. Hatch, N. M. Dunlop, W. G. Robey, L. O. Arthur, M. A. Gonda, and P. J. Fischinger. 1987. Simple, rapid, quantitative, syncytiumforming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retroviruses 3:283-302.
12. Nara, P. L., and P. J. Fischinger. 1988. Quantitative infectivity assays for HIV-1 and -2. Nature 332:469-470.
13. Otvos, L., Jr., I. O, M. E. Rogers, P. J. Consolvo, B. A. Condie, S. Lovas, P. Bulet, and M. Blaszczyk-Thurin. 2000. Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 39:14150-14159.
14. Ratner, L., W. Haseltine, R. Patarca, K. J. Livak, B. Starcich, S. F. Josephs, E. R. Doran, J. A. Rafalski, E. A. Whitehorn, K. Baumeister, et al. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313: 277-284.
15. Robinson, W. E., B. McDougall, D. Tran, and M. E. Selsted. 1998. Anti-HIV-1 activity of indolicidin, an antimicrobial peptide from neutrophils. J. Leukoc. Biol. 63:94-100.
16. Turpin, J. A. 2002. Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin. Investig. Drugs 11:1077-1097.
17. Wachinger, M., A. Klenschmidt, D. Winder, et al. 1998. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression. J. Gen. Virol. 79:731-740.
18. Wang, G., K. M. Watson, and R. W. Buckheit, Jr. 2008. Anti-human immunodeficiency virus type 1 activities of antimicrobial peptides derived from human and bovine cathelicidins. Antimicrob. Agents Chemother. 52:3438-3440.
19. Wang, G., X. Li, and Z. Wang. 2009. APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res. 37:D933-D937.
20. Wang, Z., and G. Wang. 2004. APD: the antimicrobial peptide database. Nucleic Acids Res. 32:D590-D592.
21. 7)-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule. Biochem. Biophys. Res. Commun. 215:626-631.
22. Weislow, O. S., R. Kiser, D. L. Fine, J. Bader, R. H. Shoemaker, and M. R. Boyd. 1989. New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDSantiviral activity. J. Natl. Cancer Inst. 81:577-586.
23. Zasloff, M. 2002. Antimicrobial peptides of multicellullar organisms. Nature 415:359-365.